Investigating the Impact of TPST-1120 PPAR ¿ Inhibition on Anti-PD-1 Antibody Immunotherapy Efficacy in Pre-Clinical Melanoma Models

Administered By

Awarded By

Contributors

Start/End

  • June 28, 2018 - December 24, 2021